It would seem to me that given Elanco's position (world's No 2 animal health company) they can not afford NOT to take up the option. Are they prepared to pass on MPL and allow the opposition to do a deal with PAA. To me the question now is how much is the royalty and other payments worth and is PAA in a good position (right people etc) to negotiate the best deal for shareholders?
“The combination with Elanco will give rise to a leading competitor in the animal health industry, benefiting customers, employees and shareholders alike,” he said.The acquisition will also add additional bench strength and scale to Elanco’s world-class R&D team. Buying the Bayer division will significantly bulk up Elanco’s pet business"
- Forums
- ASX - By Stock
- PAA
- Ann: Final Report delivered under Option Agreement
Ann: Final Report delivered under Option Agreement, page-148
-
- There are more pages in this discussion • 314 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.45M |
Open | High | Low | Value | Volume |
21.0¢ | 21.5¢ | 20.5¢ | $106.7K | 516.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 24033 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 55077 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24033 | 0.205 |
10 | 437026 | 0.200 |
7 | 307849 | 0.195 |
13 | 836896 | 0.190 |
19 | 458709 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 55077 | 2 |
0.215 | 314891 | 4 |
0.220 | 305364 | 5 |
0.225 | 119118 | 2 |
0.230 | 163181 | 4 |
Last trade - 15.22pm 22/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |